CS Paper Radar

Conditional Diffusion-Based Generation of T2-Weighted Prostate MRI for Clinically Significant Prostate Cancer Classification

Xavier Rafael-Palou, Alejandro Vergara-Richart, Ignacio Iborra Roncales, Carmen Prieto-de-la-Lastra, Andreu Antolin-Redondo, Juan Morote, Ana Jimenez-Pastor

cs.CV ·submitted 2026-11-01 20:54 UTC · v2

Abstract

Scarce and unrepresentative training data limit the performance of prostate MRI prediction models. Synthetic T2-weighted (T2W) MRI may augment training data containing clinically significant prostate cancer (csPCa) and transition zone (TZ) lesions. In this retrospective, single-center, ethics-committee-approved study, we developed a conditional generative model for T2W prostate MRI extending MAISI-v2 with csPCa class, zonal, and lesion-mask-guided conditioning, incorporating a relative advantage weighted loss fine-tuned on 1,303 patients (1,654 lesions). Fidelity was assessed by incremental ablation, and downstream utility was evaluated with T2W-based csPCa classifiers across five simulated training-data scenarios, each testing 18 synthetic-data configurations. The proposed model reduced Fréchet inception distance (FID) from 13.28 (pretrained MAISI-v2) to $2.04 \pm 0.06$ internally (PI-CAI: $3.83 \pm 0.51$). Synthetic augmentation significantly increased AUC in all five scenarios (+0.027 to +0.088; adjusted $p = 0.016$--$0.043$), though cross-institutional augmentation of PI-CAI yielded a non-significant gain (+0.013; $p = 0.397$). Overall, our model improved T2W MRI fidelity, and synthetic images improved csPCa classification under simulated data constraints, although benefit did not transfer significantly across institutions.

Closest papers

Nearest neighbours by meaning across the whole index.

Diffusion-Based Synthesis of Complete 3D Biparametric Prostate MRI

cs.CV ·2026-10-22 ·Claudia Giardina, Montse Pardàs, Verónica Vilaplana
publishedhot direction similarity 0.74
Abstract · Presented at the 6th Deep Generative Models Workshop (DGM4MICCAI), MICCAI 2026

Synthetic biparametric MRI (bpMRI) may help alleviate the limited availability of large and representative prostate MRI datasets for deep learning applications. In this work, we present a conditional 3D diffusion framework for anatomy-conditioned synthesis of complete prostate bpMRI from anatomical masks. The framework supports sequential synthesis, in which T2w and diffusion modalities are generated by separately trained models, and joint synthesis, in which all bpMRI modalities are generated simultaneously within a single model. Five configurations were trained using PI-CAI, FastMRI Prostate, and PROSTATEx datasets to investigate different conditioning schemes, target modalities, and synthesis strategies. Evaluation using distribution-based metrics, paired-image similarity, and qualitative assessment demonstrated the feasibility of both synthesis pathways. Joint synthesis achieved competitive distributional fidelity while generating complete bpMRI, whereas direct synthesis of ADC and computed high-b-value DWI outperformed their derivation from synthetic diffusion-weighted images.

0.34

Technically Plausible but Clinically Misleading? Expert Evaluation of Patient-Personalized Synthetic Prostate MRI

eess.IV ·2026-08-17 ·Gabriel Paulo Maglalang Israel, Sol Gedde, Alvaro Fernandez-Quilez
published similarity 0.71
Abstract · To appear in SCAI 2026 proceedings

Magnetic resonance imaging (MRI) is central to prostate cancer assessment, yet its acquisition is costly and time-consuming, making it a major bottleneck in the patient care pathway. Personalized MRI synthesis is a promising direction because it may allow the generation of clinically realistic images tailored to individual patients while reducing the dependence on scanner-acquired imaging. In this work, we in-vestigate whether patient-personalized MRI synthesis produces images that experts perceive as clinically plausible and how such personaliza-tion influences expert interpretation. We synthesize patient-personalized prostate MRI using a 3D diffusion model conditioned on routine pre-imaging clinical variables age and PSA. Using a large publicly available dataset, we first verify that synthesized images are technically compara-ble to scanner-acquired MRIs using standard image similarity metrics. We then conduct a pilot, single-blinded, randomized expert study on a subset of cases sampled to reflect variation in patient clinical pro-files. A radiologist compared personalized and unconditioned synthetic MRIs using paired assessments and Likert-scale ratings of clinical plausibility, confidence, and risk of misleading interpretation, supplemented by qualitative feedback. Although personalized synthetic MRIs appeared technically plausible, expert interpretation highlighted variability in con-fidence and potential risks of misleading cues when routine clinical data was embedded into image generation. These findings suggest that while personalized synthesis may be technically feasible, careful assessment is needed to understand how generated cues influence clinician interpreta-tion before such systems can be safely integrated into clinical workflows.

0.33

A cross-modal generative model for incomplete and degraded prostate MRI with multicentre clinical validation

eess.IV cs.AIcs.CV ·2026-08-17 ·Siyuan Ma, Liang He, Mengying Zhu, Yi Chai, Mengyao Lyu +12 more
published similarity 0.70
Abstract

Missing or degraded sequences can limit prostate multiparametric MRI. We developed MSCNet, a sequence-conditioned cross-modal generative framework for reconstructing unavailable contrasts and restoring degraded acquisitions. Across ten completion tasks, task-specific MSCNet achieved mean structural similarity of 0.818 versus 0.798 for the strongest task-matched comparators; matched-capacity analyses showed larger differences in lesion fidelity and boundary preservation. In a blinded 1,000-case reader study, overall image quality met the prespecified non-inferiority criterion for DWI, ADC and T2W completion, but not T1W. In a separate 200-case diagnostic assessment, AUCs for clinically significant cancer were 0.860 with acquired images, 0.841 with MSCNet and 0.797 with baseline-generated images. A locked 186-case three-hospital cohort supported multicentre transportability. These retrospective results support quality-controlled cross-modal reconstruction as an adjunct to acquired prostate MRI.

0.47

CONTEXT-PCa: Evaluating the role of clinical context in MRI-based AI for detecting clinically significant prostate cancer (study protocol)

cs.AI ·2026-11-14 ·Shiqi Huang, Weixi Yi, Shaheer Ullah Saeed, Yipei Wang, Wen Yan +7 more
similarity 0.69
Abstract

The objective of this study is to investigate the role of clinical variables - their breadth, source, and quality - in the development, utility, and generalisability of an AI system for bi-parametric MRI (bpMRI)-based diagnosis of clinically significant prostate cancer (csPCa). Clinical context is added to the published PI-CAI-2B image-only model, whose weights are fixed. The study cohort comprises 6,022 biparametric MRI cases from 4,540 patients at University College London Hospitals NHS Foundation Trust (2019-2024), of which 4,834 cases (3,632 patients) are held out for internal testing. Forty-three clinical variables are drawn from structured health records, clinical letters, MRI reports, and automated image measurements. The primary endpoint is the difference in the area under the receiver operating characteristic curve (AUROC) between the image-context and image-only models on the internal test set. Secondary analyses compare combining strategies, the contribution of individual variables, and performance across subgroups. All models are further tested on five external cohorts from primary diagnosis and population-based screening.

0.20

Improving PI-RADS Prediction and Prostate Cancer Detection from Multiparametric MRI with Anatomical Guidance

cs.CV cs.AI ·2026-11-03 ·Seungbin Park, Thibault Heintz, Rachit Saluja, Francesca Khani, Timothy McClure +3 more
similarity 0.67
Abstract

Accurate prediction of Prostate Imaging Reporting and Data System (PI-RADS) scores from multiparametric MRI (mpMRI) remains challenging, more so than clinically significant prostate cancer (csPCa) detection. Given the importance of lesion location in PI-RADS scoring, we evaluated whether incorporating prostate zonal masks improves PI-RADS prediction and csPCa detection across multiple architectures (3D ResNet-18, ResNet-50, and ViT) using a large-scale internal dataset. Anatomical guidance generally improved performance across architectures, with the best results achieved by ResNet-18 with 2-zone guidance for PI-RADS prediction (QWK = 0.511) and ResNet-50 with 5-zone guidance for csPCa detection (AUC = 0.809). Fine-tuned results on external datasets further demonstrated the benefits of anatomical guidance. Furthermore, models with anatomical guidance improved the utility of model-predicted PI-RADS scores for PI-RADS-based csPCa detection (positive defined as PI-RADS>=3). Combining model-predicted and expert-assigned PI-RADS scores significantly increased the AUC from 0.711 to 0.756 (p < 0.05), suggesting that AI-derived PI-RADS scores may provide complementary information to expert assessment for csPCa detection. Overall, our findings highlight the value of incorporating prostate zonal anatomy into deep learning-based prostate MRI assessment.

0.24

Lesion-Aware Adaptive Fourier Neural Operator for CT-to-PSMA PET Synthesis in Prostate Cancer

cs.CV physics.med-ph ·2026-08-11 ·Rashmi Bhaskara, Waleed M. Almutairi, Matthew Gopaulchan, Maram Musaad Alqurashi, Francis Asamoah +3 more
similarity 0.66
Abstract

Deep learning models that synthesize PET from CT or MRI can reduce patient dose and scanner demand, but are typically optimized with global losses such as L1 or mean squared error (MSE) that treat all voxels similarly. In whole-body PSMA-PET, tumor voxels occupy only a small fraction of the volume, yet carry the clinically relevant activity signal; as a result, models can achieve high structural similarity index measure (SSIM) and peak signal-to-noise ratio (PSNR) while still underestimating lesion activity or failing to preserve tumor-specific structure. Radiomics provides biologically meaningful descriptors of tumor intensity and texture, but direct radiomics conditioning is time-consuming because it requires feature extraction from delineated lesion regions. We propose LAFNO, a Lesion-Aware Adaptive Fourier Neural Operator for CT-to-PSMA-PET synthesis that replaces high-dimensional radiomics conditioning with two efficient CT-derived proxy channels. Motivated by radiomics analysis of PSMA-avid tumor core and peritumoral regions, LAFNO uses a contrast proxy for local density variation and a disorder proxy for local texture heterogeneity, both injected into the model bottleneck. LAFNO combines whole-volume reconstruction with lesion-level total lesion activity (TLA), tumor-core contrast, and peritumoral supervision. We evaluated LAFNO against four baseline architectures on the TCIA PSMA-PET-CT-Lesions dataset. LAFNO remained competitive on whole-volume image quality, achieving SSIM of 0.960 and 0.938 for 18F- and 68Ga-PSMA, respectively, while reducing per-patient TLA error to 48.3% and 64.0% for 18F- and 68Ga-PSMA, respectively, and achieving the highest tumor-core radiomics reproducibility across all feature classes for both tracers. Peritumoral reproducibility remained tracer-dependent, indicating that biological fidelity in synthetic PSMA-PET remains challenging.

0.04

ProtoCouncil: Multi-Encoder Anatomical Prototypes for Prostate Cancer Detection in Micro-Ultrasound

cs.CV cs.AIcs.LG ·2026-11-06 ·Mohammad Mahdi Abootorabi, Nooshin Maghsoodi, Armin Saadat, Obed Dzikunu, Zhuoxin Guo +6 more
similarity 0.65
Abstract · 12 pages, 3 figures, Under Review

Purpose: Micro-ultrasound ($μ$US) is a promising modality for prostate cancer (PCa) detection, but identifying suspicious tissue depends heavily on clinical experience. Models trained on sparse, noisy core-level pathology offer little insight into their decisions and can fail under domain shift. Clinical use needs a traceable decision process and a flag for uncertain predictions. Methods: We introduce ProtoCouncil, in which three foundation encoders (MedSAM, DINOv3 and V-JEPA 2.1) learn case-based prototypes at three anatomical levels: whole gland, needle track and gland sectors. Prototypes are projected onto real training-core regions, and label-free fusion keeps every class logit as a bias plus an exact sum of prototype similarity contributions. Encoder disagreement triggers selective prediction. Results: In five-fold patient-level cross-validation (6,588 cores, 693 patients), ProtoCouncil reaches 82.9% AUROC for clinically significant PCa (csPCa, Grade Group $\geq$3), 4.3 points above the best previously published method. In zero-shot evaluation on two external cohorts, ProtoCouncil achieves higher all-cancer and csPCa AUROC than all previous methods. Nearest same-class exemplars match test-core tumor involvement better than random same-class cases. Externally, csPCa accuracy falls from 79% when encoders agree to 27% when two oppose the fused call. Abstaining on disagreement raises balanced accuracy by 7 and 15 points, while retaining 58% and 54% of the cores. Conclusion: ProtoCouncil grounds core-level predictions in exact similarity-based evidence from real, anatomically indexed training cases, which makes its reasoning interpretable. It achieves the highest csPCa AUROC across three cohorts and identifies unreliable predictions through encoder disagreement.

0.30

Learning Prostate Anatomy at Test Time for Cancer Detection in Micro-Ultrasound

cs.CV cs.LG ·2026-08-20 ·Obed Korshie Dzikunu, Mohammad Mahdi Abootorabi, Mohamed Harmanani, Paul F. R. Wilson, Emma Willis +5 more
code/data similarity 0.65
Abstract

Domain shift across clinical centers using different imaging hardware or acquisition protocols remains a fundamental barrier to deploying deep learning models for prostate cancer (PCa) detection. Existing test-time adaptation (TTA) methods address distribution shift through entropy minimization or augmentation-based self-supervision, correcting for statistical differences in image appearance but ignoring the anatomical structure of the target domain. We propose ANT, a segmentation-guided TTA framework that adapts a pretrained cancer detection encoder to the target domain by solving an auxiliary prostate segmentation task at test time, supervised by pseudo-masks from a frozen pretrained segmentation network. By aligning encoder representations to prostate anatomy in the target domain, ANT corrects domain-specific feature drift while preserving cancer-discriminative structure. The model was trained on 693 patients imaged with an earlier-generation micro-ultrasound scanner in a multi-center clinical trial, and evaluated on 118 patients acquired with a newer-generation system across two centers in another clinical trial. Under a leave-one-center-out protocol with identical evaluation conditions across all methods, ANT improves mean AUC by 2.9% and 3.6% at the biopsy-core and patient levels, respectively, over no adaptation, outperforming TTA baselines. Code is available at: https://github.com/ObedDzik/ant.git.

0.52